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The presence of axillary enlarged lymph nodes in the follow-up of a woman with a history of breast
cancer should always be thoroughly indagated.
Dermatopathic lymphadenopathy presents a speciﬁc pathologic pattern found within the lymph nodes
and is usually associated with cutaneous rashes.
Patients with various skin conditions can develop regional lymphadenopathy, which can result in the
asymptomatic enlargement of the lymph nodes, especially in the inguinal, axillary and cervical regions.
Dermatopathic lymphadenopathy should be considered in the differential diagnosis also in patients
with minimal cutaneous ﬁndings.
Dermatopathic lymphadenopathy is a benign process and management of these patients consists in
simple clinical, mammographic and ultrasonographic follow-up.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The presence of axillary enlarged lymph nodes in the follow-up
of a woman with a history of breast cancer should always be
thoroughly indagated.
Axillary nodes larger than 1.5 cm that do not contain a fatty
hilum may be considered abnormal [1]. In a series evaluating
axillary abnormalities, the most frequent cause of axillary aden-
opathy was nonspeciﬁc benign lymphadenopathy (29% of cases),
followed by metastatic breast cancer (26%) and chronicSurgical and Dental Sciences,
aly.
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phoma (17%). Other causes included collagen vascular disease,
lymphomas other thanwell-differentiated lymphocytic lymphoma,
metastatic disease for primary site other than breast, sarcoidosis,
human immunodeﬁciency virus-related lymphadenopathy, psori-
asis and reactive lymphadenopathy associated with a breast ab-
scess [2].
Reactive axillary nodal enlargement is common after breast
biopsy [3]. It is also frequently seen after infection or inﬂammation
of the upper extremity or breast. When nodal enlargement without
an obvious cause is seen and the node maintains a benign
appearance, no further intervention is usually needed other than
correlation with clinical ﬁndings to exclude worrisome palpable
axillary adenopathy [3].
Follow-upmammography is a reasonable alternative to biopsy if
the patient has no history of malignancy, the amount of increase in
nodal size is small and the node maintains a benign appearance.
In a study by Lee et al. [4] considering patients who had
unilaterally enlarging axillary or intramammary lymph nodes o
otherwise normal mammograms, the majority of those who.
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showed a decrease in the size of the enlarged nodes.
If a mammographically benign-appearing mass is identiﬁed in
the outer breast in association with infection or dermatitis, der-
matopathic lymphadenitis should be considered [5].
A size increase of 100% or more over baseline size and
morphologic features such as change in shape, spiculation of the
margins, loss of a radiolucent center or hilar notch and increase in
density should increase the degree of suspicion for malignancy [4].
Homogenously dense axillary lymph nodes were strongly
associated with malignancy when they were longer than 33 mm,
had ill-deﬁned or spiculated margins or contained intranodal
microcalciﬁcation and the patient had no history of gold therapy for
rheumatoid arthritis [2].
In a study conducted to evaluate mammographic ﬁndings in
breast infection and biased to include those patients with more
severe inﬂammation, abnormally dense and enlarged lymph nodes
were not observed in any case, although not all axillary lymph
nodes were visualized at mammography [6].
The primary tumor within the breast is usually depicted mam-
mographically when lymph nodes enlarge because of metastatic
breast cancer [7]. However the tumor may be occult [7,8].
The normal US appearance of a lymph node is that of a hypo-
echoic mass withwell-circumscribedmargins and a fatty echogenic
hilum.Withmalignancy, the fatty hilummay be lost, the shapemay
become irregular and calciﬁcations can be seen [9]. The presence of
nodal spiculation suggests an aggressive tumor [10].2. Case report
We report a case of a 65 years old woman who underwent left
upper-outer quadrant quadrantectomy and axillary dissection for
breast cancer in 2005. At a follow-up mammography performed in
September 2013, she presented some enlarged lymph nodes at the
level of the contralateral axilla.
Axillary masses appeared as mobile, nontender, ﬁrm subcu-
taneous nodules at physical examination. No masses were present
at both breasts examination.
No skin lesions were present at the level of both upper limbs and
breasts. No alterations were present at blood laboratory
examinations.
Mammographic appearance of the lymph nodes did not show
any change in shape, spiculation of the margins, intranodal
microcalciﬁcation, but they appeared as homogenously dense,Fig. 1. Ultrasonography showing an enlarged (34.1 mm) hypoechoic mass with well-
circumscribed margins and fatty echogenic hilum at the level of the right axilla.without a radiolucent center and one of themmeasured more than
35 mm (Fig. 1).
No suspect densities or masses were described at the level of
both breasts at mammography.
Ultrasonography showed right axilla enlarged hypoechoic
masses with well-circumscribed margins and fatty echogenic hi-
lum, one lymph node measuring 34.1 mm (Fig. 2).
In relation to the breast cancer history of the patient lymph node
cytology was performed.
Cytology revealed reactive paracortical hyperplasia with
vascular proliferation and eosinophil granulocytes inﬁltration, with
an increased number of interdigitating dendritic cells and Langer-
hans cells and negative immunocytochemistry staining for CK-Pan.
Cytology diagnosed a dermatopathic lymphadenopathy, in the
absence of clear cutaneous involvement. The patient had a history
of psoriasis, without any skin lesion at the moment of the lymph-
adenopathy diagnosis.
Only clinical, mammographic and ultrasonographic follow-up
was requested for the patient, who shows a stability of the clin-
ical and imaging ﬁndings at one year from diagnosis.
3. Discussion
Dermatopathic lymphadenopathy (DL) was originally described
by Pautrier and Woringer in French in 1937 but the name derma-
topathic lymphadenitis was coined and published in English by
Hurwitt in 1942 [11].
Dermatopathic lymphadenopathy is a benign process with a
speciﬁc pathologic pattern found within the lymph nodes and is
usually associated with cutaneous rashes.
Patients with various skin conditions can develop regional
lymphadenopathy, which can result in the asymptomatic enlarge-
ment of the lymph nodes, especially in the inguinal, axillary and
cervical regions. The lymph nodes are generally mobile, nontender,
ﬁrm subcutaneous nodules.Fig. 2. Mammographic oblique view of the right breast showing homogenously dense
enlarged axillary masses.
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extensive dermatitis, particularly in those with exfoliative derma-
titis [12]. It is also found in patients with erythroderma, psoriasis,
atopic dermatitis and infectious rashes such as those of fungal
origin [13]. Peripheral blood eosinophilia can be present; some-
times with a percentage as high as 35% [2].
Rarely DL can be seen in patients with minimal cutaneous
ﬁndings [14], such as in our patient, who only presented a light
form of psoriasis years before and who did not present any skin
lesion at the moment of lymphadenopathy diagnosis.
Histopathologic ﬁndings in dermatopathic lymphadenopathy
are characteristic [14]. In almost all cases, the follicular pattern is
retained. The germinal centers are usually slightly enlarged and
surrounded by a rim of lymphocytes. The most conspicuous feature
is the enlarged paracortical area, appearing as pale patches because
the majority of cells are macrophages and pale-staining cells of
three types: lymphocytes, Langerhans cells and interdigitating re-
ticulum cells [12,14]. Pigment is usually seen in the cytoplasm and
in extracellular deposits [14].
In a large series of consecutive lymph node biopsy specimens,
Cooper and colleagues diagnosed DL in 4.8% of specimens [15]. DL
occurred twice as often in males as in females and most patients
had associated skin disease. However 12% of patients in their study
had no clinical evidence of skin disease and similar experience is
reported by others [15,16]. The benign skin diseases commonly
associated with DL are often exfoliative or eczematoid: toxic-shock
syndrome, pemphigus, psoriasis, neurodermatitis, eczema and
atrophia senilis [11e17]. Skin disease is often present month to
years before lymph node is performed [11]. Gould and colleagues
studied over 1000 axillary lymph nodes from 50 consecutive radical
mastectomy specimens performed in women with breast cancer
[16]. They identiﬁed mild to moderate dermatopathic changes in
approximately 15% of lymph nodes, but only one patient had active
skin disease (contact dermatitis) [17]. Thus, mild dermatopathic
changes do not correlate as well with skin disease as full-blown DL.
In addition, DL does not always correlate with contemporary skin
irritation and sometimesmay reﬂect a history of dermatitis that has
healed [17].
Dermatopathic lymphadenopathy is also a common reaction
pattern in patients with mycosis fungoides (MF) and Sezary syn-
drome (SS). Approximately 75% of patients with MF/SS have
palpable lymphadenopathy at time of diagnosis [17], explained by
the presence of DL, MF/SS or a combination of both. The presence of
lymphadenopathy in MF/SS patients correlates with a poorer
prognosis, regardless of histologic ﬁndings (i.e. DL vs. MF/SS) [17].
Possibly, this may be true because it is difﬁcult to distinguish DL
from early or minimal involvement by MF/SS. Several studies have
attempted to make this distinction in lymph nodes. In cases in
which involvement by MF/SS is extensive, or MF/SS focally replaces
lymph node architecture, DL and MF/SS can be distinguished reli-
ably [17]. However most authors have concluded that minimal
histologic evidence of MF/SS in draining regional lymph nodes is
not characteristic and that conﬁdent distinction between DL and
minimal involvement by MF/SS cannot be made using histologic
criteria [16e27]. Molecular studies allowing detection of a mono-
clonal T-cell population can be helpful in identifying minimal MF/
SS in lymph nodes; however, the clinical signiﬁcance of a small
monoclonal T-cell population in the absence of obvious histologic
involvement is not well established [28].
In the follow-up of a breast cancer patient the possibility of a
dermatopathic lymphadenopathy should always be considered in
the differential diagnosis with a metastatic involvement of axillary
lymph nodes, even when clear dermatologic lesions are not
present.Ethical approval
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